Newsroom

Download the UCLB Annual Review as a PDF ...

Conference Call and Webcast to Be Held Tuesday, April 2, 2019 at 8:00 am ET / 1:00 pm BST UCLB ...

 Revolutionary technology developed at UCL Engineering that guides surgeons performing biopsies and improves prostate cancer detection has been featured on ...

UCLB, the wholly owned subsidiary technology commercialisation company of UCL, has appointed Dr Anne Lane as its new Managing Director ...

London, UK, December 17th, 2018.  LifeArc, a leading UK medical research charity, is delighted to launch a new Technology Transfer ...

Medical software developed at UCL that overlays tumour information from MRI scans onto ultrasound images can help guide surgeons conducting ...

The government has published the second Life Sciences Sector Deal, which outlines public and private sector investments into the sector ...

A single infusion of FLT180a resulted in sustained mean Factor IX activity of 45%, with no toxicity or adverse effects, ...

UCLTF has invested in a series A round for immuno-oncology company IGEM Therapeutics. The £5million funding round also included investment ...

AI spinout Hazy, featured in a recent Forbes list selecting the 15 Machine Learning Companies to Watch in Europe. Hazy ...

Engitix Ltd, a company pioneering the development of both tissue-specific and disease-specific human extracellular matrix (ECM) for accelerating and improving ...

SmartTarget Ltd, a spinout of UCL (University College London) that has developed a CE-approved device for precision prostate biopsy and ...

Simon Goldman and David Grimm, who are responsible for managing investments for the UCL Technology Fund, the fund co-managed by ...

UCL spinout Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene ...

UCLB spinout Orchard Therapeutics, a biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases ...